N-Alkoxy Analogues of 3,4,5-Trihydroxypiperidine
N-n -P r op oxy-[3S(e),4(e),5S(a )]-3,4,5-tr ih yd r oxyp ip er i-
J . Org. Chem., Vol. 63, No. 19, 1998 6475
to the generalized reductive cyclization procedure to give
piperidine 20 (220 mg, 0.67 mmol, 42%): Rf ) 0.40 (10%
EtOAc/petroleum ether); 1H NMR (200 MHz, CDCl3) δ 5.91
(3H, m), 5.20 (6H, m), 4.10-4,35 (6H, m) 3.64 (2H, t, J ) 6.2
Hz,), 3.41-3.52 (4H, m), 3.20 (1H, t, J ) 11.5 Hz), 2.38 (2H, t,
J ) 11.6 Hz), 1.43 (4H, m), 0.90 (3H, t, J ) 7.2 Hz); 13C NMR
(50 MHz, CDCl3) δ 136.0, 135.5, 117.1, 116.6, 86.1, 76.6, 74.5,
72.7, 72.3, 58.2, 31.4, 19.9, 14.5. Anal. Calcd for C18H31NO4:
C, 66.43; H, 9.60; N, 4.30. Found: C, 66.22; H, 9.51; N, 4.35.
O-n -Bu t yl N-[(2R,3S,4R)-2,3,4-t r ia llyloxy-5-h yd r oxy-
p en tyl]h yd r oxyla m in e 22. To a solution of the oxime 18
(685 mg, 2.01 mmol) and NaBH3CN (380 mg, 6.03 mmol) in
MeOH (30 mL) was added concentrated HCl (2 mL) at room
temperature. The reaction mixture was stirred for 1 h and
then concentrated in vacuo. The residue was purified by
column chromatography (silica gel) to provide hydroxylamine
22 (668 mg, 1.94 mmol, 97%): Rf ) 0.25 (33% EtOAc/petroleum
d in e (5). 37% overall yield; [R]25 ) +6.0 (c ) 10, CH3OH);
D
1H NMR (200 MHz, CD3OD) δ 3.97 (1H, m), 3.83 (1H, m), 3.65
(2H, t, J ) 6.5 Hz), 3.47 (1H, br), 2.20-3.40 (4H, br), 1.56 (2H,
m), 0.92 (3H, t, J ) 7.4 Hz); 13C NMR (50 MHz, CDCl3) δ 76.7,
70.4, 70.1, 61.9, 24.4, 12.9. Anal. Calcd for C8H17NO4: C,
50.25; H, 8.96; N, 7.32. Found: C, 50.20; H, 9.03; N, 7.28.
6-O-{1-[3(e),4(a ),5(e)]-3,4,5-Tr ih yd r oxyp ip er id in yl}-D-
ga la ctose (7a ). 53% overall yield; [R]25D ) +34.0 (c ) 1, H2O);
1H NMR (200 MHz, D2O) δ 5.25 (1H, d, J ) 3.3 Hz), 4.57 (1H,
d, J ) 7.7 Hz), 3.40-4.25 (9H, m), 2.80-3.20 (4H, br); 13C NMR
(50 MHz, D2O) δ 99.4, 95.3, 75.8, 75.4, 74.8, 74.6, 74.1, 73.0,
72.9, 72.6, 72.2, 72.0, 71.3, 70.9, 68.6, 56.6. Anal. Calcd for
C
11H21NO9‚0.5H2O: C, 41.25; H, 6.92; N, 4.37. Found: C,
41.79; H, 6.80; N, 4.41.
6-O-{1-[3(e),4(a ),5(e)]-3,4,5-Tr ih yd r oxyp ip er id in yl}-D-
glu cose (7b). 37% overall yield; [R]25 ) +55.0 (c ) 1, H2O);
D
1H NMR (200 MHz, D2O) δ 5.19 (1H, d, J ) 3.7 Hz), 4.61 (1H,
d, J ) 11.8 Hz), 3.31-4.10 (9H, m), 3.20 (2H, br), 2.80 (2H,
br); 13C NMR (50 MHz, D2O) δ 98.9, 95.0, 78.8, 77.1, 76.8, 75.8,
ether); H NMR (200 MHz, CDCl3) δ 5.91 (3H, m), 5.20 (6H,
1
m), 3.58-4.21 (15H, m), 3.21 (1H, dd, J ) 11.5, 5.0 Hz), 2.97
(1H, dd, J ) 11.5, 7.3 Hz), 1.45 (4H, m), 0.92 (3H, t, J ) 7.3
Hz). Anal. Calcd for C18H33NO5: C, 62.95; H, 9.68; N, 4.08.
Found: C, 62.83; H, 9.64; N, 4.07.
74.4, 73.7, 73.6, 73.0, 72.5, 68.6, 56.5. Anal. Calcd for C11H21
-
NO9‚H2O: C, 40.12; H, 7.03; N, 4.25. Found: C, 39.96; H, 6.86;
N, 3.97.
P r oced u r e for th e Mitsu n obu Cycliza tion . N-Bu tyl-
oxy-[3(e),4(e),5(e)]-3,4,5-tr ia llyloxyp ip er id in e (20). To a
solution of 22 (665 mg, 1.93 mmol) in anhydrous THF (100
mL) were added Ph3P (1.02 g, 3.86 mmol) and DEAD (0.67
mL, 4.25 mmol) at room temperature. The reaction mixture
was stirred overnight at room temperature and then concen-
trated in vacuo. The residue was purified by silica gel column
chromatography to afford 20 (470 mg, 1.45 mmol, 75%): Rf )
0.60 (20% EtOAc/petroleum ether).
(2R,3S,4R)-2,3,4-Tr is(a llyloxy)-5-tosyloxyp en ta n a l O-n -
Bu tyloxim e (19). A solution of methyl â-D-xylopyranoside
(10 g, 61.0 mmol) in DMSO (150 mL) was treated with 50%
aqueous NaOH (25 mL, 311 mmol) and stirred until it became
homogeneous. Allyl bromide (23.8 mL, 274 mmol) was then
added. The reaction mixture was stirred until no starting
material was detected by TLC and extracted with Et2O (2 ×
250 mL). The combined organic layers were washed with
water (2 × 100 mL), dried over magnesium sulfate, and
concentrated in vacuo. The resulting crude product was
dissolved in a solution of AcOH (100 mL) and 2 N sulfuric acid
(100 mL), and the mixture was refluxed until no starting
material was detected by TLC. After workup (saturated
NaHCO3, 250 mL; EtOAc, 2 × 250 mL) and column chroma-
tography (silica gel) purification, triallylxylose 17 (13.0 g, 48.2
mmol) was isolated in 79% yield. Rf ) 0.50 (40% EtOAc/
petroleum ether).
Gen er a lized Dea llyla t ion P r oced u r e. N-Bu t yloxy-
[3(e),4(e),5(e)]-3,4,5-tr ih yd r oxyp ip er id in e (6). A mixture
of 20 (600 mg, 1.85 mmol), Rh(PPh3)3Cl (120 mg, 0.13 mmol),
DABCO (41 mg, 0.37 mmol), EtOH (18 mL), and water (2 mL)
was refluxed for 1 h. The resultant solution was treated with
2 N HCl (20 mL) and refluxed for another hour. The reaction
mixture was cooled to room temperature and washed with CH2-
Cl2 (40 mL). The aqueous layer was collected and concentrated
in vacuo. The anhydrous residue was treated with a mixture
of Ac2O (1.3 mL, 13.45 mmol) and Et3N (5 mL) in CH2Cl2 (25
mL) and was stirred overnight. After workup (water, CH2-
Cl2) and column chromatography purification, triacetate 23
(507 mg, 1.53 mmol) was isolated in 83% yield. Compound
23 was subjected to basic Amberlite (1 g) in MeOH (10 mL) at
room temperature overnight. The resin was filtered off, and
the filtrates were concentrated and dried to give 6 (314 mg,
1.53 mmol, 100%) as a white solid. 23: 1H NMR (200 MHz,
CDCl3) δ 5.14 (2H, br), 4.99 (1H, t, J ) 9.1 Hz), 3.55 (2H, t, J
) 6.5 Hz), 3.42 (2H, dd, J ) 12.0, 4.6 Hz), 2.50 (2H, t, J )
11.5 Hz), 1.93 (6H, s), 1.92 (3H, s), 1.38 (4H, m), 0.82 (3H, t,
J ) 7.1 Hz); 13C NMR (50 MHz, CDCl3) δ 170.5, 170.1, 74.2,
72.7, 68.5, 56.1, 31.1, 21.3, 19.8, 14.4. 6: 1H NMR (200 MHz,
CDCl3) δ 5.15 (3H, br), 3.50 (7H, m), 2.46 (2H, br), 1.40 (4H,
m), 0.90 (3H, t, J ) 7.2 Hz); 13C NMR (50 MHz, CDCl3) δ 79.7,
72.4, 68.8, 59.7, 31.3, 19.9, 14.5. Anal. Calcd for C9H19NO4:
C, 52.65; H, 9.33; N, 6.83. Found: C, 52.50; H, 9.24; N, 6.66.
A solution of O-n-butylhydroxylamine hydrochloride (315
mg, 2.51 mmol) in MeOH (10 mL) was treated with NaOH
(100 mg, 2.51 mmol) and stirred for 15 min prior to the
addition of a solution of 17 (565 mg, 2.09 mmol) in MeOH (10
mL) at room temperature. The mixture was stirred overnight,
concentrated in vacuo, and purified by column chromatography
(silica gel) to provide oxime 18 (710 mg, 2.08 mmol, 99%) as a
mixture of two isomers (E/Z ) 3/1): Rf ) 0.6 (33% EtOAc/
1
petroleum ether); H NMR (200 MHz, CDCl3) δ 7.36 (0.75H,
d, J ) 7.9 Hz, E isomer), 6.82 (0.25H, d, J ) 6.0 Hz, Z isomer),
5.85 (3H, m), 5.20 (6H, m), 3.60-4.20 (13H, m), 2.41 (1H, br),
1.63 (2H, m), 1.38 (2H, m), 0.92 (3H, t, J ) 7.1 Hz); 13C NMR
(50 MHz, CDCl3) δ 151.5, 148.2, 135.3, 134.4, 117.9, 117.3,
80.8, 79.5, 76.8, 74.2, 72.5, 70.5, 62.0, 31.6, 19.5, 14.4. Anal.
Calcd for C18H31NO5: C, 63.32; H, 9.15; N, 4.10. Found: C,
63.34; H, 9.17; N, 4.05.
To the solution of oxime 18 (600 mg, 1.76 mmol), pyridine
(3 mL), and several crystals of DMAP was added tosyl chloride
(503 mg, 2.64 mmol). The reaction mixture was stirred for 1
h at room temperature. After workup (ice water, 100 mL;
Et2O, 2 × 100 mL) and column chromatography (silica gel)
purification, oxime tosylate 19 (798 mg, 1.61 mmol) was
isolated in 92% yield: Rf ) 0.60 (20% EtOAc/petroleum ether);
1H NMR (200 MHz, CDCl3) δ 7.80 (2H, d, J ) 7.3 Hz), 7.33
(1H, d, J ) 6.9 Hz), 7.23 (2H, d, J ) 7.3 Hz), 5.78 (3H, m),
5.20 (6H, m), 4.33 (1H, dd, J ) 4.5, 11.0 Hz), 4.12 (1H, t, J )
6.9 Hz), 4.03 (2H, t, J ) 6.2 Hz), 4.02-4.10 (6H, m), 3.80 (2H,
m), 3.52 (1H, t, J ) 4.5 Hz), 2.42 (3H, s), 1.62 (4H, m), 0.90
(3H, t, J ) 7.2 Hz); 13C NMR (50 MHz, CDCl3) δ 14.4, 19.5,
22.1, 31.6, 70.5, 70.6, 72.8, 73.8, 74.2, 76.2, 76.7, 79.3, 117.8,
118.1, 128.4, 130.2, 133.3, 134.3, 134.8, 145.2, 147.9.
Ack n ow led gm en t. We thank the American Cancer
Society, the NSF Faculty Early Career Development
Program, and the donors of the Petroleum Research
Fund, administered by the American Chemical Society,
for support of this work. P.L. acknowledges the New
York University Dean’s Dissertation Fellowship.
Su p p or t in g In for m a t ion Ava ila b le: 1H and 13C NMR
spectra of the final products and intermediates (51 pages). This
material is contained in libraries on microfiche, immediately
follows this article in the microfilm version of the journal, and
can be ordered from the ACS; see any current masthead page
for ordering information.
N -Bu t yloxy-[3(e ),4(e ),5(e )]-3,4,5-t r ia llyloxyp ip e r i-
d in e (20). The oxime 19 (790 mg, 1.60 mmol) was subjected
J O971535M